{"name":"Russian Academy of Medical Sciences","slug":"russian-academy-of-medical-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Mucofalk","genericName":"Mucofalk","slug":"mucofalk","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Resveratrol Pill","genericName":"Resveratrol Pill","slug":"resveratrol-pill","indication":"Cardiovascular health support","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"cyclosporine or tacrolimus","genericName":"cyclosporine or tacrolimus","slug":"cyclosporine-or-tacrolimus","indication":"Organ transplant rejection prophylaxis (kidney, heart, liver, pancreas)","status":"marketed"}]}],"pipeline":[{"name":"Mucofalk","genericName":"Mucofalk","slug":"mucofalk","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Resveratrol Pill","genericName":"Resveratrol Pill","slug":"resveratrol-pill","phase":"marketed","mechanism":"Resveratrol is a polyphenolic compound that activates sirtuins and other cellular stress-response pathways to promote antioxidant and anti-inflammatory effects.","indications":["Cardiovascular health support","Metabolic and anti-aging applications"],"catalyst":""},{"name":"cyclosporine or tacrolimus","genericName":"cyclosporine or tacrolimus","slug":"cyclosporine-or-tacrolimus","phase":"marketed","mechanism":"Cyclosporine and tacrolimus are calcineurin inhibitors that suppress T-cell activation by blocking the transcription of pro-inflammatory cytokines.","indications":["Organ transplant rejection prophylaxis (kidney, heart, liver, pancreas)","Autoimmune diseases including rheumatoid arthritis and lupus nephritis","Atopic dermatitis and other inflammatory skin conditions"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNQ0k2N1ZMWVpfZEtITTJQLVAzZGJYT0dveE1CUXVEVURmUGZKck4ycGtqcXZWVWh2MnZ4dG5KclpFQ1VUejB0ZzdQdUJFMFp1QWZ0TFE0RzJZRWdSbkw2QkJXQ081V0M0NEZrWG1WdW1kQm12enFQVi1VWUFzZnNQcHRQVlNybkQxLWM0?oc=5","date":"2026-03-04","type":"pipeline","source":"Mirage News","summary":"UK Taskforce Launches to Secure Medical Science Futures - Mirage News","headline":"UK Taskforce Launches to Secure Medical Science Futures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOOW9ZbDU2cGwwUUd0Ym5zVzJPN3RFeUJHWEFVa0JocmVLeFlkTlFFb0RlNmpqV0JQQ0FUSmhleWxaWXI3OUdtcWNOT0dzc05VWjRZRWltMEs3QnFxdlBieTlIUC1sWTFCT3BOSkkyTVhYYTl6SGpMdWNNeDdOTHhOVmI4YVJkcG92SVFmcFlkTjhKM1lPZzVUX3BQbUNJQdIBngFBVV95cUxOOW9ZbDU2cGwwUUd0Ym5zVzJPN3RFeUJHWEFVa0JocmVLeFlkTlFFb0RlNmpqV0JQQ0FUSmhleWxaWXI3OUdtcWNOT0dzc05VWjRZRWltMEs3QnFxdlBieTlIUC1sWTFCT3BOSkkyTVhYYTl6SGpMdWNNeDdOTHhOVmI4YVJkcG92SVFmcFlkTjhKM1lPZzVUX3BQbUNJQQ?oc=5","date":"2026-02-05","type":"pipeline","source":"Новости GxP","summary":"Department of Prophetic Medicine to Be Established in Afghanistan - Новости GxP","headline":"Department of Prophetic Medicine to Be Established in Afghanistan - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOMEpoa1diNjAteGwzYl9Sc3kxQU84RW41aUVuUzIzNTFGRUFDRnliM3ZNTktqUDFUMFJzRldZMlpXdGwzb0wtSEZSOW5aekV0dzFLMGpFV3oya2dtQVlfdkJqa1JWSjNXWjhiQV9JVDNuSnFfR3JDbmZucTJXNnl1ZGZpYS1kU0JxWVNCWE5faTJLYUpZNDVySDNEb3d0WVdrQlhXWnAwVEtsaVJwQUJua3Z2TlpKOG91RU44ang1TG50clF2WDBwMElqQlQ3SWdVVTA3X3ZfVzFZcklzb3owd9IB5gFBVV95cUxNRGM2OGFlTEZhckRhM3dCSG0wTFJ5ZjkzNEpCNmFlbDl0eXNXZlpERXYyYnNzV3g2MWlNbXV2cUd1U0pheE9qQnhOUEt6bEtGcUUtUUdMT2tWMEN1U0c1cVpzUWM5eVR5RmdEaE9LaVFWVHdpZ2dIUl9MVlNsOURzTmMxWmRJY0Q4OEMza1hHQ1BackJrdDhYMkRWRlVHYWI3VEhiM1VZUFMzbUExak9Vd0FZMU5UaWloV21VY3g3MVdTbDZIZk0ydnFMQWFmelJmdWpzSXJ1VTNZYmhvUmoyTklyTGNzUQ?oc=5","date":"2025-09-08","type":"trial","source":"Medical Dialogues","summary":"Russia's Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use - Medical Dialogues","headline":"Russia's Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-09-08","type":"pipeline","source":"Business Standard","summary":"Cancer breakthrough? Russia's mRNA vaccine shows 100% early success - Business Standard","headline":"Cancer breakthrough? Russia's mRNA vaccine shows 100% early success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOd0JXYnBNaWh2bWlUREh3MTlleVQ2UWpTUjhwM2x5ZDBsbnRLdGlwR2FyR014LTRJTFJzSEdUT3pTSV8tQUFac3JnQV9vTnFiSFgwXzNnTEZGaE5uZzNtdWhsVERMVnBvUnhUQkZYbFRlZU4xLW1JVk40MmRxY3lZczZxTkFNMjZhU3p5N1VQUWFDWTk5WHFhSFVXay14SEUwOHZpVlZoc0hpTTM2ZXpV0gGvAUFVX3lxTE53QldicE1paHZtaVRESHcxOWV5VDZRalNSOHAzbHlkMGxudEt0aXBHYXJHTXgtNElMUnNIR1RPelNJXy1BQVpzcmdBX29OcWJIWDBfM2dMRkZoTm5nM211aGxURExWcG9SeFRCRlhsVGVlTjEtbUlWTjQyZHFjeVlzNnFOQU0yNmFTenk3VVBRYUNZOTlYcWFIVVdrLXhIRTA4dmlWVmhzSGlNMzZlelU?oc=5","date":"2025-06-20","type":"trial","source":"Новости GxP","summary":"Amedart will hold clinical trials of the first domestic biosimilar of Koselugo - Новости GxP","headline":"Amedart will hold clinical trials of the first domestic biosimilar of Koselugo - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPTi1LbkktY19zZkFybWtDdGFDVWxGZlpPVGpSWEJEQ21pdGQyV1F4VE5VLTVfckx1MGFJSDF5dldiNXFXMzRrbVEyZmRheVd6ZEpEZGJ5YW9QaFZaMDBQNlJoam9BRVVsdTdfeU9HZWVYZ1oyTUZOUUR2VDNHS0JlNVlfVUo5VUpmNk1EWGk3SEpsdHU1cDAwOA?oc=5","date":"2025-05-23","type":"pipeline","source":"t-invariant.org","summary":"Homeopathic Offensive: The Duma Conquered, the RAS Under Siege - t-invariant.org","headline":"Homeopathic Offensive: The Duma Conquered, the RAS Under Siege - t","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-22","type":"pipeline","source":"The Hindu","summary":"JSSAHER gets into space medicine research - The Hindu","headline":"JSSAHER gets into space medicine research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWV9QTlIxR0V4Z1hBbGlDUVZEWG5hb1NYRzFwWmVlZlA1S0lMR0h0akFrVGlKZy1NWnozc3gtdGg2Vm44TDNTejlKdWVOLVY2OWlEdkZEZmUtVmVBRk9mSkhwY1BVYlZMcVAycmdIUS1ldUVhSFN6M0NWWWw1LWhVSVpjbGltZHowWjQ5a0p5YjNscGllcDYtM0ViTk1tZmZGYjJZdDFSaWJXN1Vrb0IxOHpvMU5nVHJOZ19rTlVQUVFQTFpDS1Fj?oc=5","date":"2024-07-23","type":"regulatory","source":"The New York Academy of Sciences","summary":"Equivalence of Complex Drug Products: Scientific and Regulatory Challenges - The New York Academy of Sciences","headline":"Equivalence of Complex Drug Products: Scientific and Regulatory Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQcGlwbFdZTlhGcndJc09yUkM3UjFoeGZfOW5hNVZ1WHVFV3BPaVk5b3lWa3JMQzhnV0NNaXIwS0NvVEQ1aXZmZmxRdmpNcFNYLTFuelVwNjJJR05CSERwc0s2aGoyS2dPdzgyTERLWmFpazRydl9zemdwdUdlRnlyUXZUZ3NDMm8?oc=5","date":"2023-08-16","type":"pipeline","source":"Northeastern Global News","summary":"Biochemist, author, art collector, Soviet émigré. How Vladimir Torchilin became a renowned scientist on both sides of the Iron Curtain - Northeastern Global News","headline":"Biochemist, author, art collector, Soviet émigré. How Vladimir Torchilin became a renowned scientist on both sides of th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOQTM5emJyT2RPZXhjSEVjdl9Ed3R5cWt3MWtlOWp1cHUyTG9rcVVyRjM4eVZvNTVpOW1UaDBHWENMMmhDelRZTzRvV2FiekpQaTd2d2FaWjg3U2w3SzJ1bTN4UTNNYktqV1RXaFpIM3lVX2hHdjRhbTYtVUVrVTNxcWxTaG5TUVZxQm1WRHZteVk?oc=5","date":"2023-06-09","type":"deal","source":"FNIH","summary":"FNIH and Eli Lilly Launch US-Russia Science Partnership - FNIH","headline":"FNIH and Eli Lilly Launch US-Russia Science Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNM0NJM1RpSHlKNEkxdFQ3QzVtM19QVElBTVF5SkpqZTJzaFF4dGF2RU94ZkRlZnJzREtjRTJFUUoyLWQ1ZUdMSmhFODM3V2RkRzRqemk1V2I2VUx1cEJnUy1URFM0Vi1VeFhKSXhJZzY5QTJFSzlmeUJORVc0SEM4SUdPR2tULU1Xa2c?oc=5","date":"2022-05-09","type":"pipeline","source":"Foreign Policy Research Institute","summary":"The Rise of Sino-Russian Biotech Cooperation - Foreign Policy Research Institute","headline":"The Rise of Sino-Russian Biotech Cooperation","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}